Clinical Predictors of Recurrent Non-Alcoholic Steatohepatitis Following Liver Transplantation for Non-Alcoholic Fatty Liver Disease.

被引：4
|
作者：
Stein, L. [1 ]
Dunn, W. [2 ]
Nguyen, H. [1 ]
Bhasin, D. [1 ]
Pollinger, H. [1 ]
Johnson, M. [1 ]
Shrestha, R. [1 ]
机构：
[1] Piedmont Transplant Inst, Atlanta, GA USA
[2] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-02392
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A408
引用
收藏
页码：703 / 703
页数：1
相关论文
共 50 条
  • [31] Liver transplantation and non-alcoholic fatty liver disease
    Zezos, Petros
    Renner, Eberhard L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15532 - 15538
  • [32] Liver transplantation and non-alcoholic fatty liver disease
    Petros Zezos
    Eberhard L Renner
    World Journal of Gastroenterology, 2014, (42) : 15532 - 15538
  • [33] Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis
    Le, Thuy-Anh
    Loomba, Rohit
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (02) : 156 - 173
  • [34] Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
    Lirussi, F.
    Mastropaqua, E.
    Orando, S.
    Orlando, R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [35] Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
    Angelico, F.
    Burattin, M.
    Alessandri, C.
    Del Ben, M.
    Lirussi, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [36] What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
    Doumas, Michael
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios G.
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (05) : 425 - 428
  • [37] The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Zhang, Chunye
    Liu, Shuai
    Yang, Ming
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (02) : 148 - 161
  • [38] Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Ahsan, Farah
    Oliveri, Federico
    Goud, Harshit K.
    Mehkari, Zainab
    Mohammed, Lubna
    Javed, Moiz
    Althwanay, Aldanah
    Rutkofsky, Ian H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [39] Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Dowman, J. K.
    Tomlinson, J. W.
    Newsome, P. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) : 525 - 540
  • [40] The importance of regular screening for HCC in non-alcoholic steatohepatitis/non-alcoholic fatty liver disease
    Keitoku, Taisei
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Uchihara, Naoki
    Suzuki, Keito
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Ishido, Shun
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Huang, Hiroyuki Nakanishi Daniel
    Izumi., Namiki
    Red, Musashino
    JOURNAL OF HEPATOLOGY, 2023, 78 : S644 - S644
12345